Farallon Capital Partners, L.P. → EXELIXIS, INC. EXEL

Stake: 5.90% Shares: 15,709,500 CUSIP: 30161Q104 Class: Common Stock, par value $0.001 per share (the "Shares")

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 12.67

30,913,414 shares short · +8.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $37.52M

Point72 Asset Mgmt

Post-Filing Returns · since 2026-01-01 on EXEL

+1 day

0.0%

+5 days

+0.2%

+30 days

-1.8%

+60 days

-5.9%

+90 days

+1.1%

+180 days

+31.0%

Anchor price 43.58 on closest trading day on/after 2026-01-01. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on EXELIXIS, INC.

Filed	Form	Filer	Stake	Shares
2025-05-20	SCHEDULE	Farallon Capital Partners, L.P.	6.80%	18,635,500	view →
2025-03-05	SCHEDULE	Farallon Capital Partners, L.P.	8.40%	23,439,500	view →
2023-06-02	SC	Caligan Partners LP	—	—	view →
2018-01-04	SC	Meditor Group Ltd	—	—	view →

Other Filings by Farallon Capital Partners, L.P.

Filed	Form	Issuer	Stake	Shares
2026-05-29	SCHEDULE 13G	BridgeBio Pharma, Inc. BBIO	—	—	view →
2025-05-20	SCHEDULE	EXELIXIS, INC. EXEL	6.80%	18,635,500	view →
2025-03-05	SCHEDULE	EXELIXIS, INC. EXEL	8.40%	23,439,500	view →
2023-11-07	SC	Cazoo Group Ltd	—	—	view →
2023-04-27	SC	Cazoo Group Ltd	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →